Analysis of dysarthria in a 55-year-old female patient with multiple sclerosis by means of an IT tool based on respiratory and phonatory examination – a case study

Ładowanie...
Obrazek miniatury
Data
2023-09
Autorzy
Warmbier, Wojciech A.
Popiel, Małgorzata
Guzik, Agnieszka
Drużbicki, Mariusz
Bartosik-Psujek, Halina
Tytuł czasopisma
ISSN
Tytuł tomu
Wydawnictwo
Publishing Office of the University of Rzeszow
Abstrakt
Introduction and aim. There are no available objective tools for assessing dysarthric disorders in the course of multiple sclerosis (MS). The aim of the study is to analyse a case of mixed dysarthria in a 55-year-old female patient in the course of secondary progressive MS and to present the severity of the patient’s dysarthric disorder in contrast with the control group as evaluated by means of an IT tool based on respiratory and phonatory examination. Description of the case. A 55-year-old patient was admitted to the Clinic of Neurology with the Stroke Unit due to a worsening condition in the course of MS. She was examined with an objective tool for respiratory and phonatory disorders. Her results were, then, compared to those of 24 healthy individuals from the control group, matched in terms of sex and age. Following speech parameters were analysed: phonetics of utterances, number of produced syllables per breath during the execution of individual texts, sound quality, intonation, and the total performance time of each. Conclusion. The analysed case indicates that the developed objective IT tool is a promising diagnostic method that can facilitate diagnosis and can be used in clinical practice.
Opis
All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Bioethical Committee at the University of Rzeszów (approval no. 3/01/2020).
Słowa kluczowe
dysarthria , multiple sclerosis , respiratory and phonatory disorders
Cytowanie
European Journal of Clinical and Experimental Medicine T. 21, z. 3 (2023), s. 648-653